Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Passage Bio: Q1 Earnings Insights

  Passage Bio (NASDAQ:PASG) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Passage Bio (NASDAQ:PASG) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Passage Bio beat estimated earnings by 11.24%, reporting an EPS of $-0.79 versus an estimate of $-0.89.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 3.93% drop in the share price the next day.

 

To track all earnings releases for Passage Bio visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For iRadimed

By Benzinga Insights
Today, 7:55 AM
iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that iRadimed will likely report an Earnings Per Share (EPS) of $0.21.

IRMD